Harrison, C N <br/><br/>
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.  [electronic resource] 

 -  British journal of cancer  Oct 1999 
 - 476-83 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6690718  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Carmustine--administration & dosage<br/>Child<br/>Child, Preschool<br/>Chlorambucil--administration & dosage<br/>Cohort Studies<br/>Combined Modality Therapy<br/>Cytarabine--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Etoposide--administration & dosage<br/>Female<br/>Hematopoietic Stem Cell Transplantation<br/>Hodgkin Disease--drug therapy<br/>Humans<br/>Incidence<br/>Infant<br/>Leukemia, Myeloid--chemically induced<br/>Life Tables<br/>Lomustine--administration & dosage<br/>Male<br/>Mechlorethamine--administration & dosage<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Myelodysplastic Syndromes--chemically induced<br/>Neoplasms, Second Primary--chemically induced<br/>Podophyllotoxin--administration & dosage<br/>Prednisolone--administration & dosage<br/>Prednisone--administration & dosage<br/>Procarbazine--administration & dosage<br/>Retrospective Studies<br/>Risk<br/>Salvage Therapy--adverse effects<br/>Vinblastine--administration & dosage<br/>Vincristine--administration & dosage